Walgreens Boots Alliance (WBA) Scheduled to Post Earnings on Tuesday

Walgreens Boots Alliance (NASDAQ:WBA) will release its earnings data on Tuesday, April 3rd. Analysts expect Walgreens Boots Alliance to post earnings of $1.50 per share for the quarter. Walgreens Boots Alliance has set its FY18 guidance at $5.45-5.70 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the company earned $1.10 earnings per share. On average, analysts expect Walgreens Boots Alliance to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

How to Become a New Pot Stock Millionaire

WBA stock opened at $67.47 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The firm has a market capitalization of $64,819.47, a P/E ratio of 18.64, a price-to-earnings-growth ratio of 1.08 and a beta of 1.21. Walgreens Boots Alliance has a one year low of $63.82 and a one year high of $87.79.

The business also recently declared a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were paid a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.37%. Walgreens Boots Alliance’s dividend payout ratio is 44.20%.

A number of research firms have weighed in on WBA. Pivotal Research decreased their price target on Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating for the company in a research note on Friday. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a research note on Thursday, March 22nd. TheStreet downgraded Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Tuesday, March 20th. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 22nd. Finally, Barclays began coverage on Walgreens Boots Alliance in a research note on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target for the company. One analyst has rated the stock with a sell rating, ten have issued a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus price target of $84.45.

In other Walgreens Boots Alliance news, insider Stefano Pessina purchased 98,858 shares of the firm’s stock in a transaction dated Monday, January 15th. The shares were bought at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 14.80% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance (WBA) Scheduled to Post Earnings on Tuesday” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3303478/walgreens-boots-alliance-wba-scheduled-to-post-earnings-on-tuesday.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

ANI Pharmaceuticals  Stock Rating Lowered by BidaskClub
ANI Pharmaceuticals Stock Rating Lowered by BidaskClub
Achillion Pharmaceuticals  Upgraded to “Buy” by Zacks Investment Research
Achillion Pharmaceuticals Upgraded to “Buy” by Zacks Investment Research
AstraZeneca  Given a GBX 3,750 Price Target at Goldman Sachs
AstraZeneca Given a GBX 3,750 Price Target at Goldman Sachs
Analysts Expect Teekay Tankers Ltd.  Will Post Earnings of -$0.06 Per Share
Analysts Expect Teekay Tankers Ltd. Will Post Earnings of -$0.06 Per Share
National Storage  Scheduled to Post Earnings on Wednesday
National Storage Scheduled to Post Earnings on Wednesday
Logitech  Set to Announce Earnings on Wednesday
Logitech Set to Announce Earnings on Wednesday


© 2006-2018 Ticker Report. Google+.